Investors, what stocks did you buy or sell this month?
I've been buying $MO stock this month and this week on Monday I was overbought $CVS stock as it dropped a few % again and got below the $70 level and then on Monday I was overbought $BAC and $PFE stock as they are also at a great price. As far as selling goes, I have sold off all shares of $MMM at a profit during this month.
Pfizer $PFE reported results today. You could say that the results beat expectations, but the revenue just missed expectations. Revenue was down from Q1 this year as sales of the Covid-19 vaccine fell 83% and revenue from the Paxlovide antiviral treatment fell 98%.
I've been buying $PFE shares recently as they are currently at a really low price.
Investors, which company's results surprised you the most this week and which company's results are you looking forward to next week?
I was certainly pleased with $GOOGL's results and surprised by $MMM's results as I was expecting much worse given the situation they are currently in. As for next week, I'm looking forward to and interested in the results of $PFE, $CVS, $SBUX, $AM... Read more
Investors, the pharmaceutical company Johnson & Johnson reported results today and the results beat expectations. Overall, I see potential in pharmaceutical and medical device companies and I like to invest in them. I already have $CVS in my portfolio and plan to add $PFE to my portfolio. I would like to add $JNJ to my portfolio, but it is at a high price and I fear it will be... Read more
$JNJ is probably a fine company too, such a classic. I already have $PFE and $CVS, so I'm not thinking about it though, I'd rather build those positions.
Drugmaker Pfizer $PFEsaidits North Carolina plant, one of the largest sterile injectable manufacturing facilities in the world, suffered severe damage from a tornado... Hopefully this will only be a short-term problem, as this plant produces nearly 30% of the company's sterile injectables.
The stock hasn't reacted to the news yet, so we don't have a chance to buy.
Pfizer $PFE ends development of obesity drug due to side effects. 🔴
You may remember my recent post that talked about the positive test results of Pfizer's obesity drug.
Today our stock dropped over 4% right after the market opened on the news that the development of this drug was being abruptly terminated. Pfizer said it will instead focus on its other oral obesity drug,... Read more
What sector are you primarily focused on and what sector do you see the most potential in???
My main focus lately has been on the healthcare sector, as I see huge potential there. I think the healthcare sector is still moving forward and will grow even more in the future.
When I look at how many people have some health problems and medicine is needed more and more, or how many... Read more
I understand the tobacco industry the most. Next would probably be the automotive industry, where I currently have only one representative. I also have quite a bit invested in the healthcare sector, although I don't move much in it. Then maybe 1 piece of each for diversification, my portfolio is constantly changing.
Charlie Munger and his view of healthcare in the US.
Charlie, a friend, partner of Warren, has recently been vocal about his concerns about US healthcare, literally stating that it is a system that prolongs death to make more money and comparing patients to African carcasses. 🤔
I bought $39 worth of Pfizer $PFE stock and did a little research on their future intentions, where I clearly see growth potential + a regular and stable dividend. What about you?
Lately, it has been mostly technology stocks that have been up a few dozen percent. However, I am wondering what you currently see as potential buying opportunities.
I've been buying stocks recently, $MMM and $DIS. However, I am planning on buying shares of $CVS and $PFE.
Views on the current price and future of Pfizer $PFE?
The company is entering "the most important 18 months in Pfizer's history," CEO Bourla said in February. That's because the company plans to launch or expand the registration of 19 drugs over the next year and a half.
I guess it depends a lot if there's another pandemic coming or not... If so, I would definitely buy! :-D If not, this company is not interesting to me...
That's thanks to the results of a study showing the same, and potentially higher, efficacy of the new oral weight loss pills than competitor Novo Nordisk's popular Ozempic injection.
This is great news as it makes taking it easier and, for many, more affordable. However, the tablet will be further tested, but I think there is huge... Read more
I see that even if the covid ball is not solved so nice numbers cg to everyone who holds 💪 yesterday a lot of titles showed us that they are not written off yet
CVS CVS CVS :-D but obviously I should have bought Nvidia...